17140 Federal Register / Vol. 76, No. 59 / Monday, March 28, 2011 / Notices 

out of an electronic medical record, and 

the purchase and use of a mobile 

medical van. 

SPHC is an experienced provider of 

care and has a demonstrated record of 

compliance with Health Center Program 

statutory and regulatory requirements 

and is located in the same geographical 

area. The transfer of the ARRA Capital 

Improvement Project funds will ensure 

that critical primary health care services 

continue and remain available to the 

low-income, underserved homeless 

patients with no interruption in services 

to the target population. 

FOR FURTHER INFORMATION CONTACT: 

Marquita Cullom-Scott via e-mail at 

MCullom-Scott@hrsa.gov or 301–594– 

4300. 

Dated: March 23, 2011. 

Mary K. Wakefield, 

Administrator. 

[FR Doc. 2011–7248 Filed 3–25–11; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Secretary’s Advisory Committee on 

Heritable Disorders in Newborns and 

Children; Notice of Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Secretary’s Advisory Committee on 

Heritable Disorders in Newborns and 

Children. 

Dates and Times: May 5, 2011, 9:30 a.m. 

to 5 p.m., May 6, 2011, 8:30 a.m. to 3:30 p.m. 

Place: Renaissance Washington, DC, 

Dupont Circle Hotel, 1143 New Hampshire 

Avenue, NW., Washington, DC 20037. 

Status: The meeting will be open to the 

public with attendance limited to space 

availability. Participants are asked to register 

for the meeting by going to the registration 

Web site at 

http://altarum.cvent.com/event/ 

SACHDNC052011. The registration deadline 

is Tuesday, May 3, 2011. Individuals who 

need special assistance, such as sign 

language interpretation or other reasonable 

accommodations should indicate their needs 

on the registration Web site. The deadline for 

special accommodation requests is Friday, 

April 29, 2011. If there are technical 

problems gaining access to the Web site, 

please contact Maureen Ball, Meetings 

Coordinator at conferences@altarum.org. 

Purpose: The Secretary’s Advisory 

Committee on Heritable Disorders in 

Newborns and Children (Advisory 

Committee) was established to advise and 

guide the Secretary regarding the most 

appropriate application of universal newborn 

screening tests, technologies, policies, 

guidelines and programs for effectively 

reducing morbidity and mortality in 

newborns and children having or at risk for 

heritable disorders. The Advisory Committee 

as authorized under the Public Health 

Service Act 42 U.S.C. 300b–10, and amended 

in the Newborn Screening Saves Lives Act of 

2008, also provides advice and 

recommendations concerning the grants and 

projects authorized under the Public Health 

Service Act, 42 U.S.C. 300b–8, (Heritable 

Disorders Program) as amended in the 

Newborn Screening Saves Lives Act of 2008. 

Agenda: The meeting will include: (1) A 

presentation of the External Review 

Workgroup’s final report on the nomination 

of Hyperbilirubinemia to the Advisory 

Committee’s recommended uniform 

screening panel; (2) an update from the 

Evidence Evaluation Methods workgroup; 

and (3) presentations on the continued work 

and reports of the Advisory Committee’s 

subcommittees on laboratory standards and 

procedures, follow-up and treatment, and 

education and training. Proposed agenda 

items are subject to change as priorities 

dictate. You can locate the Agenda, 

Committee Roster and Charter, presentations, 

and meeting materials at the home page of 

the Advisory Committee’s Web site at http:// 

www.hrsa.gov/heritabledisorderscommittee/. 

Public Comments: Members of the public 

can submit written comments and/or present 

oral comments during the public comment 

periods of the meeting, which are scheduled 

for both days of the meeting. Those 

individuals who want to make oral 

comments are requested to register online by 

Tuesday, May 3, 2011 at http:// 

altarum.cvent.com/event/SACHDNC052011. 

Requests should contain the name, address, 

telephone number, and any professional or 

business affiliation of the person desiring to 

make an oral presentation. Groups having 

similar interests are requested to combine 

their comments and present them through a 

single representative. Written comments 

should be emailed no later than Tuesday, 

May 3, 2011, for consideration. Written 

comments should contain the name, address, 

telephone number, and any professional or 

business affiliation of the author. Submit 

written comments to Maureen Ball, Meetings 

Coordinator, Conference and Meetings 

Management, Altarum Institute, 1200 18th 

Street, NW., Suite 700, Washington, DC 

20036, telephone: 202 828–5100; fax: 202 

785–3083, or e-mail: 

conferences@altarum.org. 

Contact Person: Anyone interested in 

obtaining other relevant information should 

write or contact Alaina M. Harris, Maternal 

and Child Health Bureau, Health Resources 

and Services Administration, Room 18A–19, 

Parklawn Building, 5600 Fishers Lane, 

Rockville, Maryland 20857, Telephone (301) 

443–0721, aharris@hrsa.gov. More 

information on the Advisory Committee is 

available at http://mchb.hrsa.gov/ 

heritabledisorderscommittee. 

Dated: March 22, 2011. 

Wendy Ponton, 

Director, Office of Management. 

[FR Doc. 2011–7166 Filed 3–25–11; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Alternative Medicine; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; Neurophysiological 

and Pain Management with CAM Treatments. 

Date: April 5, 2011. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call) 

Contact Person: Hungyi Shau, PhD, 

Scientific Review Officer, National Center for 

Complementary and Alternative Medicine, 

National Institutes of Health, 6707 

Democracy Boulevard, Suite 401, Bethesda, 

MD 20892, 301–402–1030, 

Hungyi.Shau@nih.gov. 

This meeting is being published less than 

15 days prior to the meeting date due to 

scheduling conflicts. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: March 21, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–7199 Filed 3–25–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 


Emcdonald on DSK2BSOYB1PROD with NOTICES